Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Decreases Klebsiella pneumoniae RYC492 - : Diferuloylmethane {Curcumin} |
👶
In-Vitro Antibacterial Activity of Curcumin-Loaded Nanofibers Based on Hyaluronic Acid against Multidrug-Resistant ESKAPE Pathogens. Pharmaceutics (Pharmaceutics ) Vol: 14 Issue 6 Pages: Pub: 2022 May 31 Epub: 2022 May 31 Authors Snetkov P , Rogacheva E , Kremleva A , Morozkina S , Uspenskaya M , Kraeva L , Html Article Publication |
| Decreases Klebsiella pneumoniae RYC492 - : Diferuloylmethane {Curcumin} |
👶
Synergistic Biocidal Effects of Curcumin, Chitosan, and Nickel Titanate-Based Nanohybrids for Enhanced Antibacterial and Anticancer Therapies. ACS applied bio materials (ACS Appl Bio Mater ) Vol: Issue Pages: Pub: 2025 May 14 Epub: 2025 May 14 Authors Jeyasingh E , Panneerselvam HM , Chandrasekaran K , Moorthy S , Publication |
| Decreases Klebsiella pneumoniae RYC492 - : Diferuloylmethane {Curcumin} |
👶
Comparative study between two different morphological structures based on polylactic acid, nanocellulose and magnetite for co-delivery of flurouracil and curcumin. International journal of biological macromolecules (Int J Biol Macromol ) Vol: 230 Issue Pages: 123315 Pub: 2023 Mar 1 Epub: 2023 Jan 25 Authors Bakr EA , Gaber M , Saad DR , Salahuddin N , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
